after yesterdays agm statement the share price has risen 50% how much upside is left or is this another false dawn?
http://www.alexa.com/data/details/traffic_details/thewellnessshop.co.uk
womans hour link below.
http://www.bbc.co.uk/radio4/womanshour/04/2008_08_mon.shtml

http://www.dailymail.co.uk/money/article-1151825/SIMON-WATKINS-One-hours-notice-rapid-slump.html

One small private shareholder has managed to put Britain's biggest funds to shame and to prove it is possible for investors - against the odds - to bring boardrooms to account.

Susan Malin's campaign as a shareholder in Aim-listed group Ultrasis should be an inspiration. This week she stands for election to the board and she has a fair chance of success.

Then she would be able to raise all of the questions to which she and some of her fellow shareholders have been unable to get answers.

As a by-product it may even see the current chairman and chief executive removed from their posts. Setting aside the rights and wrongs of this case, it demonstrates powerfully what can be achieved by investors who play their part in making sure companies are properly run.

In the case of Ultrasis, which has no major institutions as investors, it has fallen to Malin and her fellow private investors to take the lead.

The same is not true elsewhere, such as among our banks. The roll call of individuals and organisations that failed to avert the banking disaster gets longer every day and it includes the leading shareholders, who invested billions of pounds of pension fund cash in businesses that have collapsed.

Small investors cannot be expected to know the ins and outs of complex financial instruments, but it might reasonably be expected that our biggest institutional investors were keeping a more expert and professional watch and asking probing questions about the banking system.

Malin's concerns about Ultrasis may or may not be valid, but her campaign, backed only by small private investors, should be an example to the biggest fund managers of what their responsibilities really are.

http://www.dailymail.co.uk/money/article-1151844/The-housewife-Conservative-ex-minister-shareholder-revolution.html

She is a 42-year-old accountant who gave up her job to spend the past six years quietly raising her family. He is a powerful businessman and former Conservative Health Minister.
But this week Susan Malin is threatening to unseat Gerry Malone as chairman of healthcare technology group Ultrasis in a shareholder rebellion that is sending shock waves through Britain's boardrooms as public fury grows over executive pay.

Malin has been involved in a twoyear campaign by angry Ultrasis investors who complain that executive pay packages have been poorly explained to shareholders and that Malone, 57, and chief executive Nigel Brabbins have a domineering influence over the company.

Malin stood for election to the board at an extraordinary general meeting in December and lost by a narrow margin with 48.1 per cent of the vote.

She is standing again at Ultrasis's AGM on Thursday, when she is also calling for shareholders to vote out Malone and Brabbins.

Ultrasis provides computerised therapies for depression and its 'beating the blues' program is in use throughout the NHS.

Despite this, the group made losses of 370,000 last year and its market value has slumped from more than 20million to just over 10million in 12 months.

The rebel shareholders claim that the board has not explained the performance targets for bosses to receive share options and bonuses.

Malin said: 'It looks a lot like an old boys' network to me. We are not being unreasonable - we just want to know that target-setting has been robust.'


More...Ultrasis share prices and data (thisismoney.co.uk)
Time to buy smaller company trusts? (thisismoney.co.uk)
Share deailng info (thisismoney.co.uk)

They concede that Malone's experience as a Health Minister under John Major has helped Ultrasis with its work for the NHS, but they argue that he has 'overstepped the mark'.

They say that Malone and Brabbins are a domineering force at the company and that Malone 'has not demonstrated that he understands what is in the shareholders' interests'.

Gerry Malone: On the way out?
Malin and Brabbins have held talks over their disagreements, but there has been no meeting of minds.
'What I have been trying to get across is that a lot of the issues are just about communication,' she said. 'It does take a degree of patience and forbearance to keep it on a civilised basis, but we have managed to do so.'

The last vote on Malin's appointment was close. Just a two per cent swing in her favour means she will be taking a seat on the board.

On the subject of whether the company needs to be rid of Brabbins and Malone, she said: 'I think shareholders who support us would feel relieved if there was a change at the board level.'

In a statement to Financial Mail, Brabbins, 49, said: 'Ultrasis acts in the interests of all its shareholders, of which there are more than 11,000.

'Ultrasis goes beyond what is required by the Aim rules in respect of corporate governance and has met representatives of this shareholder group on three occasions over an 18-month period, a not untypical schedule for an institution or other substantial shareholder.

'The company takes seriously any shareholder inquiries, which are answered directly by the chairman or chief executive.

'The company provides trading updates twice a year and announces to the market significant business achievements as they occur in accordance with Aim rules.
'In providing such announcements of business progress the company balances informing shareholders with the needs of commercial sensitivity.'

Malone last hit the headlines in 1997 when he lost his supposedly safe Conservative parliamentary seat of Winchester in Hampshire to Liberal Democrat Mark Oaten by two votes.

Malone challenged the result on the grounds that it was too close to be fair. A court agreed and a new election was called. He lost by a humiliating 21,000 votes.

In the elections to the Ultrasis board Malone must be hoping it is Malin who finds she is testing the voters' patience, or he could once again find himself a surprise loser.

As a Meldex holder I wish you all the luck in the World this Thursday in getting them removed from your boardfailure to do so imho will result in disaster for your investmentwith the Mail now involved you have half a chance of fair play
Maybe not half?

You have to laugh!

Ultrasis Issue of Equity





TIDMULT

RNS Number : 4770W
Ultrasis PLC
31 July 2009

?


31 July 2009


Ultrasis plc ("Ultrasis" or "the Company")


Allotment of performance shares and Block Listing Application


Ultrasis has today allotted 2,950,000 new ordinary shares in relation to the
acquisition of Get Fit Technologies Ltd on 18 December 2008. These shares (the
"bonus shares") were issued for achievement of performance criteria and
fulfilling employment obligations set at the time of acquisition. Accordingly,
application has been made for admission of 2,950,000 ordinary shares to trading
on AIM and admission is expected to be effective on 4 August 2009.


The Company has also today applied for a block listing of 111,500,000 ordinary
shares to be issued when options are exercised under the Unapproved and EMI
Share Option Scheme. The rules of the Unapproved Share Option Scheme have
recently been amended to allow for 'net settlement' which enables a fewer number
of shares to be issued in fulfilment of the existing share options thereby
reducing the dilutive effects.


Under the block listing, the shares issued following exercise of options will be
admitted to AIM as issued and Ultrasis will confirm the number of shares so
admitted every six months.

Could someone explain this to me - are directors beng given free shares ?

Rumour has it that ult have lost their NICE endorsement. Prior to feb 06 ult were on their knees with huge losses. What will happen now?

Would be surprised if they "lose" their endorsement as it is a computer based therapy and not a medication where suddenly nasty side effects have come to light

perhaps NICE has decided the "therapy" is a waste of taxpayers money.

has been proven by NICE to be cheaper and more effective than medication-anyway we will find out. Would have thought that if that was the case a RNS should have been issued

this share has been a total waste of investment capital for the last 2-3 years, with the odd flurry of excitement for those of nimble wits ..... as far as i can see, there is no reason at all to put or leave your money here

What is going on here???? 8/10 uptake in the Netherlands. 9/10 roll out in Northern Ireland. What is next France-Germany -rest of EU? ....and in 10 years time the NHS may actually get their finger out and get pct's in the UK to start using BTB as well?

I'm surprised that Labour haven't gone for Beating The Blues in a big way! ;0)

kim, of course not - u need straight jackets for them

you could just be right!

showing signs of life this week

woodie 112 to buy 107 mid they've got little shares 4 v 4

NICE guidance recommends CCBT as a mainstream treatment of choice for treating depression

Final results

Highlights:

Profit before tax of 704,000 (2008: loss of 343,000), the first in the group's history.

Revenue of 4,168,000 (2008: 2,614,000), an increase of 59% over the prior year.

Deferred income of 2,673,000 (2008: 2,142,000).

Strong cash generation.

Remains debt free, with year-end cash balances of 2,858,000 (2008: 2,036,000).

Acquisition of GetFit Technologies Limited which contributed 197,000 revenue and 91,000 profit before tax since acquisition in December 2008.

Have to say I'm amazed that these have fallen on great results.

In a good market, these would be trading at around 3-4p.

Seems to me that the AIM market has broken as nearly all stocks have siezed-up

I don't own although I did trade these a couple of mnths ago.

Agreed DD Don't know what this market needs to move sp higher unless Good results have already been factored in in recent rise.